Metabolic
2 drugs are in development for Gout.
- Companies
- 2
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Gout pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(2)
| Drug | Company |
|---|---|
| Phyto-N | Curanex Pharmaceuticals Inc (CURX) |
| synb2081 | SYNLOGIC, INC. (SYBX) |
About this indication
Gout context
Metabolic·MeSH: Gout (D006073)
Also known as: Gouts
Prevalence
756.6 / 100K
Incidence
127.5 / 100K/yr
Frequently asked questions
How many drugs are in development for Gout?
BioSniper tracks 2 drugs in development for Gout across 2 companies.
How many clinical trials target Gout?
There are 6 clinical trials targeting Gout tracked by BioSniper.
What is the prevalence of Gout?
The estimated prevalence of Gout is approximately 756.6 per 100,000 population.